Covid-19 + Universal Influenza Combination Vaccine (Vivaldi Biosciences)

N/A

Report date: 2024/12/12 11:06:34

Base Information

Drug NameCovid-19 + Universal Influenza Combination Vaccine (Vivaldi Biosciences)
Drug Alias NameDelta-19
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivaldi Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesVivaldi Biosciences
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A